ArticleScientific reports2025

Dual-drug codelivery gelatin-based hydrogel of ARV-471 and Palbociclib enhances synergistic effect in breast cancer treatment.

Irene Sevilla-Carrillo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.